Deadline Set for Generic-Drug Makers to Withdraw Pending ANDAs or Pay Fee

Washington Drug Letter
A A
Generic drugmakers have until Sept. 28 to either withdraw pending ANDAs or face a backlog fee, the FDA says.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00